Anti-inflammatory drug shows potential for improved blood formation and treatment of bone damage

Researchers at Dresden University Hospital may have discovered a new therapeutic approach for treating myelodysplastic ...
Informationsdienst Wissenschaft

MDS Therapy: Dresden Team Demonstrates Tasquinimod’s Potential for Improved Blood Formation & Treatment of Bone Damage

Researchers at Dresden University Hospital may have discovered a new therapeutic approach for treating myelodysplastic syndromes (MDS). In a recent study, the team headed by Prof. Manja Wobus and Dr.
ascopubs.org

Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes

Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study A total of 1,471 MDS patients with comprehensively annotated clinical and molecular ...